Funding for this research was provided by:
Canadian Breast Cancer Research Alliance
Canada Research Chairs
Alberta Innovates - Health Solutions
Alberta Cancer Foundation
Received: 2 December 2020
Accepted: 19 March 2021
First Online: 29 March 2021
: The authors declare that they have no conflict interests.
: In both START and CARE, ethics approval was obtained for all three sites (i.e., the Cross Cancer Institute in Edmonton, Alberta; the Ottawa Hospital Integrated Cancer Program and Cancer Center in Ottawa, Ontario; and the British Columbia Cancer Agency in Vancouver, British Columbia, Canada). The procedures used in this study adhere to the tenets of the Declaration of Helsinki.
: Informed consent was obtained from all participants in the study.
: Not applicable.